Clinical Trials Directory

Trials / Completed

CompletedNCT00361686

Comparison of Tramadol vs Remifentanyl Patient Controlled Analgesia for Second Trimester Abortions

Randomized Double Blind Study Comparing Patient Controlled Analgesia With Tramadol vs. Remifentanyl for Women Undergoing 2nd Trimester Abortions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Rabin Medical Center · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Patients undergoing second trimester abortions will recieve either patient controlled analgesia with either remifentanyl or tramadol for pain alleviation. We beleive both to be equally effective for pain alleviation.

Detailed description

Women undergoing second trimester abortions will recieve patient controlled analgesia eith either tramadol or remifentanyl. Patients will not know what they are recieving. Patients in the tramadol goup will get a loading dose of tramadol and metocloparamide while the women in the remifentanyl group will be given a loading placebo. Women will then be attached to one of the two patinet controlled analgesia protocols. Throughout their laboring process they will be monitored for blood pressure, pulse, breathing rate, sedation score and nausea. Additional medicatyion will be given for nausea. If woman are still in pain the patient controlled analgesia settings will be set to deliver a higher dose. If the woman remains in pain, she will be given an additional per os medication.If this still does not alleviate pain, the option of epidural analgesia will be offered.

Conditions

Interventions

TypeNameDescription
DRUGtramadol
DRUGremifentanyl
DEVICEpatient contolled analgesia

Timeline

Start date
2006-01-01
Primary completion
2007-01-01
Completion
2007-01-01
First posted
2006-08-08
Last updated
2015-11-24

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00361686. Inclusion in this directory is not an endorsement.